pLenti-BLRR Citations (3)

Originally described in: A multiplexed bioluminescent reporter for sensitive and non-invasive tracking of DNA double strand break repair dynamics in vitro and in vivo.
Chien JC, Tabet E, Pinkham K, da Hora CC, Chang JC, Lin S, Badr CE, Lai CP Nucleic Acids Res. 2020 Aug 14. pii: 5892751. doi: 10.1093/nar/gkaa669. PubMed Journal

---

Articles Citing pLenti-BLRR

Articles
Targeting de novo lipid synthesis induces lipotoxicity and impairs DNA damage repair in glioblastoma mouse models. Eyme KM, Sammarco A, Jha R, Mnatsakanyan H, Pechdimaljian C, Carvalho L, Neustadt R, Moses C, Alnasser A, Tardiff DF, Su B, Williams KJ, Bensinger SJ, Chung CY, Badr CE. Sci Transl Med. 2023 Jan 18;15(679):eabq6288. doi: 10.1126/scitranslmed.abq6288. Epub 2023 Jan 18. PubMed
FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism. Miao H, Meng H, Zhang Y, Chen T, Zhang L, Cheng W. Cell Death Differ. 2024 Apr;31(4):497-510. doi: 10.1038/s41418-024-01263-z. Epub 2024 Feb 19. PubMed
BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer. Sriramulu S, Thoidingjam S, Chen WM, Hassan O, Siddiqui F, Brown SL, Movsas B, Green MD, Davis AJ, Speers C, Walker E, Nyati S. J Exp Clin Cancer Res. 2024 Jun 11;43(1):163. doi: 10.1186/s13046-024-03086-9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.